“Huge Seller” Re-Pricing to Hit Sovaldi, Harvoni, Avastin, Plavix

A total of six products of four brands - Sovaldi (sofosbuvir), Harvoni (ledipasvir + sofosbuvir), Avastin (bevacizumab), and Plavix (clopidogrel) - will face a new special re-pricing rule to be rolled out in April for drugs generating “huge sales.” The...read more